GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Pparg | increases expression | ISO | PPARG (Homo sapiens) | 6480464 | CTD | kaempferol results in increased expression of PPARG mRNA; kaempferol results in increased expression of PPARG protein | PMID:25765892 | Pparg | multiple interactions | ISO | PPARG (Homo sapiens) | 6480464 | CTD | [kaempferol co-treated with Luteolin] inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]; dorsomorphin inhibits the reaction [[kaempferol co-treated with Luteolin] inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]]; kaempferol binds to and results in increased activity of PPARG protein | PMID:33049310 PMID:37308028 | Pparg | multiple interactions | ISO | Pparg (Mus musculus) | 6480464 | CTD | kaempferol binds to and results in increased activity of PPARG protein; kaempferol inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]; PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | PMID:11343698 PMID:18262572 PMID:33049310 | |
Go Back to source page | Continue to Ontology report |